ADGRG6 and urinary bladder cancer: For instance, ADGRG6 promotes breast cancer growth upon progesterone stimulation [21], serves as a mutation marker for bladder cancer recurrence and immunotherapy monitoring [34,35,36], and drives colorectal cancer proliferation via HDAC2 and GLI2 signaling [37].